Designing a Programming Language for Patient-Oriented Prescriptions

Status Completed

Clinical Trial Summary

The purpose of this study is to create a human-readable and executable computer language to implement medical prescriptions and to evaluate and refine this language, with the goal of improving safety and efficacy of patient care.

Clinical Trial Description

Preventable errors in healthcare are a leading cause of patient injury and death. Despite extensive effort and the expenditure of billions of dollars, computerization has failed to solve this problem. Research has shown that software design and debugging of a paper prescription markedly decreases the rate of injury and death associated with use of opioids in hospitalized patients. To further the application of insights from software engineering to the practice of medicine, the PIs will design and build a Patient-Oriented Prescription Programming Language (POP-PL) and evaluate if this new platform can be used to improve medical management of patients. The design of POP-PL will be based on building an understanding of the process of medical treatment of patients. This project is a collaboration between computer scientists and clinicians at Northwestern Medicine. The collaborating clinicians are co-investigators on this research project and also are providing healthcare to the patients that are being observed. The computer scientists and other research staff have undergone human subjects research training and are co-investigators on this research project as well. The clinician-investigators will oversee research project staff during all observations of patients, clinical encounters between healthcare providers and patients, and interactions between healthcare providers and healthcare information systems. Researchers involved in this study will observe interactions between health care providers and patients and will collate these observations with data from electronic data sources. Since this research is based mainly upon observation and chart review and will not involve any interventions or changes to patient care, the risk to study participants is minimal, involving inadvertent disclosure of healthcare information. This risk will be mitigated by anonymizing collected data. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02820168
Study type	Observational
Source	Northwestern University
Contact
Status	Completed
Phase
Start date	February 2016
Completion date	January 17, 2019

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03943121` - The Effects of Steroid-eluting Stent Implant for the Treatment of Eosinophilic Chronic Rhinosinusitis With Nasal Polyps	N/A
Not yet recruiting	`NCT06040151` - Evaluating Mobile-based Medication Reconciliation by Patients at Home
Completed	`NCT04151004` - Functional Muscle Characteristics and Cardio-respiratory Interaction in Patients With Fontan Palliation	N/A
Not yet recruiting	`NCT02968082` - The Effects of Preoperative Scopolamine Patch Application on the Postoperative Nausea and Vomiting in MVD Surgery	Phase 4
Completed	`NCT01240967` - To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function	Phase 1
Recruiting	`NCT06373614` - The Effect of Foot Massage and Bed Bath on Individuals With Cancer	N/A
Recruiting	`NCT06396442` - Patient Worries Previous to Dental Treatment
Recruiting	`NCT05088161` - Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques
Completed	`NCT03153579` - LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders	Phase 2
Completed	`NCT03790839` - Drug Interaction Study Between Dorzagliatin and Sitagliptin	Phase 1
Completed	`NCT02882672` - Changes in Adiponectin and Cardiovascular Disease Risk Factors in Overweight Patients	Phase 1
Withdrawn	`NCT03837418` - DESIGNING A PROGRAMMING LANGUAGE FOR PATIENT-ORIENTED PRESCRIPTIONS (POP-PL)
Completed	`NCT03282630` - The Effects of Sphenopalatine Ganglion Acupuncture in Patients With Seasonal Allergic Rhinitis	N/A
Recruiting	`NCT00001711` - Magnetic Resonance Imaging (MRI) Ofl Volunteers
Completed	`NCT01706744` - Effect of Discharge Via an Intermediate Care Unit	N/A
Completed	`NCT04584554` - Enhancing the Transition From Hospital to Home for Patients With Traumatic Brain Injury and Families	N/A
Completed	`NCT05660707` - Patients Who Underwent Surgical Procedures State of Readiness for Discharge
Completed	`NCT04632277` - Is Mg do Improve the Glycemic Control in Patients Drink a Desalinate Water	N/A
Completed	`NCT05576701` - Laughter Therapy Application in Hemodialysis Patients	N/A
Completed	`NCT03790787` - Drug Interaction Study Between Dorzagliatin and Empagliflozin	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Designing a Programming Language for Patient-Oriented Prescriptions — POP-PL

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms